Author: OurCrowd

[Alpha Tau in BioSpace] Alpha Tau announces appointment of Maya Netser to its Board of Directors; Board member Meir Jakobsohn stepping down, staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that following its Annual General Meeting of Company shareholders in Jerusalem, Ms. Maya Netser has been appointed to the Company’s Board of Directors (“Board”). Mr. Meir Jakobsohn is completing his term on the Board, having decided not to pursue re-election, but will continue to serve the Company in an advisory capacity. Read...

Read More

[ThetaRay in BusinessWire] ThetaRay caps off year of growth with four prestigious award wins

NEW YORK–(BUSINESS WIRE)–ThetaRay, a global leader in AI-driven financial crime detection and AML solutions, is thrilled to announce the receipt of four prestigious awards, cementing its position as a trailblazer in the fintech and compliance sectors. These accolades underscore a transformative year of growth, innovation, and industry recognition for the company. Read more...

Read More